Innovative framework exhibits enhanced CO evolution in CO2 photoreduction, highlighting its practical applications.
Integrating strong light harvesting with spatially isolated yet electronically coupled catalytic sites is essential for advancing heterogeneous CO2 photoreduction. Here, we report TU-62, a 2D (6,2)-connected covalent organic framework (COF) synthesized by condensing a hexatopic D3h-symmetric 2,3,6,7,10,11-hexakis(4-formylphenyl)triphenylene (HFPTP) node with a 2,2′-bipyridine-5,5′-diamine (Bpy) linker. The HFPTP unit provides an extended π-donor scaffold that reinforces long-range conjugation and efficient exciton migration, while the bipyridine linker serves as a directional electron-accepting and metal-chelatable bridge. This combination yields a highly crystalline, permanently porous, and π-conjugated hxl-topology COF ideal for photoredox applications. Postsynthetic metalation with Re(CO)5Cl affords TU-62-Re, a framework-tethered analogue of [Re(bpy)(CO)3Cl], in which the COF backbone acts as a light-absorbing antenna and electron-delocalizing support, while the immobilized Re centers serve as well-defined catalytic sites. TU-62-Re exhibits strong visible-light absorption and significantly enhanced performance relative to its homogeneous counterpart, achieving a CO evolution rate of 4.42 mmol g−1 h−1 with 95.9% selectivity under photosensitizer- and cocatalyst-free conditions. This activity surpasses all previously reported rhenium-based photocatalysts, establishing TU-62-Re as the current benchmark for Re-mediated CO2 photoreduction. Notably, under only 3% CO2, it maintains a high rate of 3.74 mmol g−1 h−1 with 97.7% selectivity, underscoring its potential for practical carbon-capture and syngas-relevant CO generation from diluted CO2 streams. Density functional theory reveals that CO2 reduction proceeds most favorably via a ligand-exchange pathway, wherein CO2 replaces a coordinated ligand at Re, dramatically lowering the overpotential and suppressing competing hydrogen evolution; explicit solvent assistance further reduces the ligand-exchange barrier.
No takes yet. Share an insight, caveat, or question.
Irie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: